Literature DB >> 10651744

Increased soluble P-selectin levels following deep venous thrombosis: cause or effect?

A D Blann1, W M Noteboom, F R Rosendaal.   

Abstract

Deep vein thrombosis (DVT) is associated with coagulation abnormalities, but evidence of excess platelet activity is scant. Soluble P-selectin is a marker of platelet activity, with high levels being found in patients with thrombotic disease. We measured soluble P-selectin by enzyme-linked immunosorbent assay (ELISA) in plasma from 89 patients with objectively confirmed DVT and in 126 healthy age- and sex-matched control subjects, and found higher levels in the patients (P = 0.011). Taking the risk of DVT with a level of soluble P-selectin < 238 ng/ml to be 1, the relative risk of DVT with a soluble P-selectin level >238 ng/ml was 2.1 (95% CI 1. 2-3.6). These high levels may be a reflection of a generalized hypercoagulable state that, with factors such as the presence of persistent thrombin generation, could be responsible for excess platelet activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651744     DOI: 10.1046/j.1365-2141.2000.01813.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

1.  Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis.

Authors:  Frank C Vandy; Cathy Stabler; Anna M Eliassen; Angela E Hawley; Kenneth E Guire; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-04-01

2.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal:  Converg Sci Phys Oncol       Date:  2017-05-17

3.  Influence of High Polyphenol Beverage on Stress-Induced Platelet Activation.

Authors:  T Nickel; K Lackermair; J Scherr; A Calatzis; M Vogeser; H Hanssen; G Waidhauser; U Schönermark; H Methe; S Horster; U Wilbert-Lampen; M Halle
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

4.  Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study.

Authors:  Locke J Bryan; Peter W Callas; Michael H Criqui; Mary Cushman
Journal:  Thromb Res       Date:  2012-08-12       Impact factor: 3.944

5.  Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.

Authors:  J A Heit; J M Cunningham; T M Petterson; S M Armasu; D N Rider; M DE Andrade
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

6.  Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients.

Authors:  Sheng-Li Ji; Hai-Yan Du; Yan-Qing Chi; Hui-Fei Cui; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

7.  Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis.

Authors:  Eduardo Ramacciotti; Susan Blackburn; Angela E Hawley; Frank Vandy; Nicole Ballard-Lipka; Cathy Stabler; Nichole Baker; Kenneth E Guire; John E Rectenwald; Peter K Henke; Daniel D Myers; Thomas W Wakefield
Journal:  Clin Appl Thromb Hemost       Date:  2011-05-17       Impact factor: 2.389

8.  A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

Authors:  J A Heit; S M Armasu; Y W Asmann; J M Cunningham; M E Matsumoto; T M Petterson; M De Andrade
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

9.  P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

Authors:  Eduardo Ramacciotti; Daniel D Myers; Shirley K Wrobleski; K Barry Deatrick; Frank J Londy; John E Rectenwald; Peter K Henke; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-04       Impact factor: 3.944

10.  Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study.

Authors:  Jiří Masopust; Radovan Malý; Ctirad Andrýs; Martin Vališ; Jan Bažant; Ladislav Hosák
Journal:  BMC Psychiatry       Date:  2011-01-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.